Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Ji Lee
Bluebird Bio Inc
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
188
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Betibeglogene Autotemcel Gene Therapy in Patients with Transfusion-Dependent, Severe Genotype β‑Thalassaemia: Results from the HGB-212 (Northstar-3) Study
Number of pages: 44
Posted: 25 Apr 2024
Janet L. Kwiatkowski
,
Mark C. Walters
,
Suradej Hongeng
,
Evangelia Yannaki
,
Andreas E. Kulozik
,
Joachim B. Kunz
,
Martin G. Sauer
,
Adrian J. Thrasher
,
Isabelle Thuret
,
Ashutosh Lal
,
Ge Tao
,
Shamshad Ali
,
Himal Takar
,
Heidi Elliot
,
Ankit Lodaya
, Ji Lee,
Richard A. Colvin
,
Franco Locatelli
and
Alexis A. Thompson
University of Pennsylvania, UCSF Benioff Children’s Hospital Oakland - Children’s Hospital Oakland Research Institute, Mahidol University - Division of Pediatric Hematology-Oncology, "G. Papanikolaou” General Hospital of Thessaloniki, University of Heidelberg, University of Heidelberg, Hannover Medical School, Great Ormond Street Hospital, Aix-Marseille University - Hôpital de la Timone, University of California, San Francisco (UCSF), Bluebird Bio Inc, Bluebird Bio Inc, Bluebird Bio Inc, Bluebird Bio Inc, Bluebird Bio Inc, Bluebird Bio Inc, Bluebird Bio Inc, Bambino Gesù Children's Hospital - Department of Pediatric Hematology and Oncology and University of Pennsylvania
Downloads
188
(422,345)
View PDF
Download
Abstract:
beta-thalassaemia, gene addition therapy, genetic vectors, lentivirus, transfusion-independence
Feedback